Canine Parainfluenza + Bordetella Bronchiseptica Vaccine

Verify with FDA CVM →

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
14
Total Reports
3
Deaths Reported
2140.0%
Death Rate

Active Ingredients

Canine Parainfluenza + Bordetella Bronchiseptica Vaccine

Administration Routes

NasalUnknownParenteral

Species Affected

Dog 14

Most Affected Breeds

Retriever - Labrador 3
Boxer (German Boxer) 2
Corgi (unspecified) 1
Terrier - Boston 1
Bichon Frise 1
Hound - Basset 1
Retriever - Golden 1
Terrier - Bull - Miniature 1
Pit Bull 1
Mountain Dog - Bernese 1

Most Reported Reactions

Vomiting 9
Death 3
Weight gain 3
Bloody diarrhoea 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Other abnormal test result NOS 2
Diarrhoea 2
Lethargy (see also Central nervous system depression in Neurological) 2
Not eating 2
Sleepiness - neurological disorder 1
Reduced responses 1
Limpness 1

Outcome Breakdown

Recovered/Normal
5 (35.7%)
Ongoing
4 (28.6%)
Died
3 (21.4%)
Outcome Unknown
2 (14.3%)

Data Summary

Metric Value
Total adverse event reports 14
Reports involving death 3
Case-fatality rate (reported events) 2140.0%
Distinct species in reports 1
Distinct breeds in reports 11
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Canine Parainfluenza + Bordetella Bronchiseptica Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 14 adverse event reports referencing Canine Parainfluenza + Bordetella Bronchiseptica Vaccine, including 3 reports in which the animal died — a 2140.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Canine Parainfluenza + Bordetella Bronchiseptica Vaccine. Reported administration routes include Nasal, Unknown, Parenteral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Canine Parainfluenza + Bordetella Bronchiseptica Vaccine reports are Dog (14 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (3), Boxer (German Boxer) (2), Corgi (unspecified) (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Canine Parainfluenza + Bordetella Bronchiseptica Vaccine are Vomiting (9), Death (3), Weight gain (3), Bloody diarrhoea (2). Of the 14 reports with a coded outcome, Recovered/Normal is the leading category at 35.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Canine Parainfluenza + Bordetella Bronchiseptica Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial